Overexpression of IL-6 can cause chronic inflammatory disorders and potentially fatal hyperinflammation (Spencer et al., 2019), as seen in advanced coronavirus disease 2019 (COVID-19) (Mehta et al., 2020). Here, IL6 is linked to COVID-19.